Experience

Transcend Therapeutics

• United States
• Biotechnology Research
• 1 - 100 Employee

• Research And Development Manager

  • Jul 2023 - Present

• Senior Scientist

  • Jan 2022 - Aug 2023



Longevity Biotech

• United States
• Biotechnology Research
• 1 - 100 Employee

• Principal Scientist

  • Mar 2021 - Jan 2022

  • Director of preclinical studies for lead drug candidate (regulatory T cell enhancing peptide) in amyotrophic lateral sclerosis (ALS). • Lead translational clinical T cell biomarker program in ALS; overseeing timeline adherence, biomarker measurement (flow cytometry), and data analysis/interpretation. • Scientific support for business development meetings with venture capital groups and external stakeholders. • Coordinated and executed two external collaborative projects involving… Show more • Director of preclinical studies for lead drug candidate (regulatory T cell enhancing peptide) in amyotrophic lateral sclerosis (ALS). • Lead translational clinical T cell biomarker program in ALS; overseeing timeline adherence, biomarker measurement (flow cytometry), and data analysis/interpretation. • Scientific support for business development meetings with venture capital groups and external stakeholders. • Coordinated and executed two external collaborative projects involving biomarker identification in Alzheimer’s disease and biomarker validation in asthma.

• Scientist II

  • Jan 2020 - Mar 2021

  • Developed strategy for preclinical and clinical biomarker study in ALS. • Optimized and validated prospective biomarkers (via multi-color flow cytometry) as well as ex vivo functional assays. • Lead data analysis using traditional (logistic regression, ANOVA) statistical techniques in addition to machine learning (CART) and AI (SOM) techniques to bring together multi-parameter datasets in biomarker discovery for Parkinson’s disease. Defined a model with the ability to identify patients… Show more • Developed strategy for preclinical and clinical biomarker study in ALS. • Optimized and validated prospective biomarkers (via multi-color flow cytometry) as well as ex vivo functional assays. • Lead data analysis using traditional (logistic regression, ANOVA) statistical techniques in addition to machine learning (CART) and AI (SOM) techniques to bring together multi-parameter datasets in biomarker discovery for Parkinson’s disease. Defined a model with the ability to identify patients with 90% accuracy using a small dataset. • Prepared and presented data for internal meetings. • Acting as scientific support by preparing and reviewing presentations for external partners. • Mentored junior lab technicians. • Authored 4 grant applications in a variety of neurodegenerative topics, leveraging previously collected samples for genetic analysis.

• Clinical Flow Cytometry Scientist I

  • Jun 2018 - Jan 2020

  • Executed clinical biomarker study in Parkinson’s disease (multi-color flow cytometry, LC/MS, ELISA). • Performed enzymatic assays. • Prepared and presented data for internal meetings. • Awarded a grant from the Department of Defense for investigation of lead compound in ALS. • Authored or assisted in authoring 3 additional grant applications.



The Johns Hopkins University

• United States
• Higher Education
• 700 & Above Employee

• Postdoctoral Research Fellow

  • Jun 2015 - Jun 2018

  • Initiated research and development for sleep fragmentation in neonates. • Lead a cross-departmental team investigating a lead drug candidate in protecting against cognitive decline following cardiac arrest. • Collaborated within the department to begin investigating sleep disturbances in Rett syndrome, ischemia, and traumatic brain injury. • Prepared and presented data for internal meetings, five society meetings and two local meetings. • Trained and supervised three undergraduate… Show more • Initiated research and development for sleep fragmentation in neonates. • Lead a cross-departmental team investigating a lead drug candidate in protecting against cognitive decline following cardiac arrest. • Collaborated within the department to begin investigating sleep disturbances in Rett syndrome, ischemia, and traumatic brain injury. • Prepared and presented data for internal meetings, five society meetings and two local meetings. • Trained and supervised three undergraduate students. Show less • Initiated research and development for sleep fragmentation in neonates. • Lead a cross-departmental team investigating a lead drug candidate in protecting against cognitive decline following cardiac arrest. • Collaborated within the department to begin investigating sleep disturbances in Rett syndrome, ischemia, and traumatic brain injury. • Prepared and presented data for internal meetings, five society meetings and two local meetings. • Trained and supervised three undergraduate… Show more • Initiated research and development for sleep fragmentation in neonates. • Lead a cross-departmental team investigating a lead drug candidate in protecting against cognitive decline following cardiac arrest. • Collaborated within the department to begin investigating sleep disturbances in Rett syndrome, ischemia, and traumatic brain injury. • Prepared and presented data for internal meetings, five society meetings and two local meetings. • Trained and supervised three undergraduate students. Show less



University of South Carolina

• United States
• Higher Education
• 700 & Above Employee

• Graduate Assistant

  • Aug 2009 - May 2015

  • Designed, conducted, and completed research on motivational dysregulation in HIV-1. • Moved a compound from in vitro cell culture to in vivo testing demonstrating the therapeutic potential of a naturally occurring isoflavone compound in mitigating synaptic and behavioral dysfunction. • Dissertation work contributed to an NIH grant examining the neurobiological mechanisms of apathy in HIV-1 associated neurocognitive disorders (HAND). • Teaching Assistant or Instructor of Record for 7… Show more • Designed, conducted, and completed research on motivational dysregulation in HIV-1. • Moved a compound from in vitro cell culture to in vivo testing demonstrating the therapeutic potential of a naturally occurring isoflavone compound in mitigating synaptic and behavioral dysfunction. • Dissertation work contributed to an NIH grant examining the neurobiological mechanisms of apathy in HIV-1 associated neurocognitive disorders (HAND). • Teaching Assistant or Instructor of Record for 7 semesters. Show less • Designed, conducted, and completed research on motivational dysregulation in HIV-1. • Moved a compound from in vitro cell culture to in vivo testing demonstrating the therapeutic potential of a naturally occurring isoflavone compound in mitigating synaptic and behavioral dysfunction. • Dissertation work contributed to an NIH grant examining the neurobiological mechanisms of apathy in HIV-1 associated neurocognitive disorders (HAND). • Teaching Assistant or Instructor of Record for 7… Show more • Designed, conducted, and completed research on motivational dysregulation in HIV-1. • Moved a compound from in vitro cell culture to in vivo testing demonstrating the therapeutic potential of a naturally occurring isoflavone compound in mitigating synaptic and behavioral dysfunction. • Dissertation work contributed to an NIH grant examining the neurobiological mechanisms of apathy in HIV-1 associated neurocognitive disorders (HAND). • Teaching Assistant or Instructor of Record for 7 semesters. Show less